Does ERTAPENEM Cause Product use issue? 55 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 55 reports of Product use issue have been filed in association with ERTAPENEM (INVANZ). This represents 1.4% of all adverse event reports for ERTAPENEM.
55
Reports of Product use issue with ERTAPENEM
1.4%
of all ERTAPENEM reports
5
Deaths
11
Hospitalizations
How Dangerous Is Product use issue From ERTAPENEM?
Of the 55 reports, 5 (9.1%) resulted in death, 11 (20.0%) required hospitalization, and 2 (3.6%) were considered life-threatening.
Is Product use issue Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for ERTAPENEM. However, 55 reports have been filed with the FAERS database.
What Other Side Effects Does ERTAPENEM Cause?
Drug ineffective (1,001)
Macular degeneration (776)
Off label use (372)
Product use in unapproved indication (346)
Pyrexia (279)
Nausea (277)
Confusional state (263)
Pain (255)
Malaise (220)
Weight decreased (220)
What Other Drugs Cause Product use issue?
INFLIXIMAB (12,752)
DUPILUMAB (10,575)
POLYETHYLENE GLYCOL 3350 (9,432)
METHOTREXATE (8,185)
DICLOFENAC (8,009)
RITUXIMAB (6,948)
ADALIMUMAB (6,379)
ETANERCEPT (6,062)
TOCILIZUMAB (5,944)
ABATACEPT (5,915)
Which ERTAPENEM Alternatives Have Lower Product use issue Risk?
ERTAPENEM vs ERTUGLIFLOZIN PIDOLATE
ERTAPENEM vs ERYTHROMYCIN
ERTAPENEM vs ERYTHROMYCIN ETHYLSUCCINATE
ERTAPENEM vs ERYTHROMYCIN LACTOBIONATE
ERTAPENEM vs ERYTHROPOIETIN